ARCHIVES

Advisors Call for External Oversight, Coordination of NCI Clinical Trials.

This article is from The Cancer Letter archive.

Vol. 31 No. 08 | February 25, 2005

Download PDF Visit The Full Archive

Related Articles

NCAB Accepts Plan for Organ Systems Program, Remains Split On Some Issues

February 11, 1983

Addition of Cobimetinib Boosts PFS in BRAF Mutation-Positive Patients in Phase III Trial

July 25, 2014

Broder: Downward Negotiations Or Coercion? NCI Authorities

June 15, 1990

Research Regulation: NRC fines NIH for Not Securing Radioactive Materials

September 13, 1996

DCT Advisors Approve Recompetition Of Drug Discovery Groups

June 23, 1995

Amgen Halts Phase III Trial Of Ganitumab Plus Gemcitabine

August 31, 2012